Unexpected Absence of the Epstein-Barr Virus (EBV) lyLMP-1 Open Reading Frame in Tumor Virus Isolates: Lack of Correlation between Met129 Status and EBV Strain Identity
- 1 April 2003
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 77 (7) , 4415-22
- https://doi.org/10.1128/jvi.77.7.4415-4422.2003
Abstract
The lytic cycle-associated lytic latent membrane protein-1 (lyLMP-1) of Epstein-Barr virus (EBV) is an amino-terminally truncated form of the oncogenic LMP-1. Although lyLMP-1 shares none of LMP-1's transforming and signal transducing activities, we recently reported that lyLMP-1 can negatively regulate LMP-1-stimulated NF-κB activation. The lyLMP-1 protein encoded by the B95-8 strain of EBV initiates from methionine 129 (Met129) of the LMP-1 open reading frame (ORF). The recent report that Met129 in the B95-8 LMP-1 ORF is not conserved in the Akata strain of EBV prompted us to screen a panel of EBV-positive cell lines for conservation of Met129 and lyLMP-1 expression. We found that 15 out of 16 tumor-associated virus isolates sequenced encoded an ATT or ACC codon in place of ATG in the LMP-1 ORF at position 129, and tumor cell lines harboring isolates lacking an ATG at codon 129 did not express the lyLMP-1 protein. In contrast, we found that EBV DNA from 22 out of 37 healthy seropositive donors retained the Met129 codon. Finally, the lyLMP-1 initiator occurs variably within distinct EBV strains and its presence cannot be predicted by EBV strain identity. Thus, Met129 is not peculiar to the B95-8 strain of EBV, but rather can be found in the background of several evolutionarily distinct EBV strains. Its absence from EBV isolates from tumors raises the possibility of selective pressure on Met129 in EBV-dependent tumors.Keywords
This publication has 49 references indexed in Scilit:
- Epstein-Barr Virus LMP-1 Natural Sequence Variants Differ in Their Potential To Activate Cellular Signaling PathwaysJournal of Virology, 2001
- The Molecular Epidemiology and Evolution of Epstein‐Barr Virus: Sequence Variation and Genetic Recombination in the Latent Membrane Protein‐1 GeneThe Journal of Infectious Diseases, 1999
- Carboxy Terminal Variants of Epstein‐Barr Virus–Encoded Latent Membrane Protein 1 during Long‐Term Human Immunodeficiency Virus Infection: Reliable Markers for Individual Strain IdentificationThe Journal of Infectious Diseases, 1999
- Epstein-barr virus immortalization and latencyFrontiers in Bioscience-Landmark, 1999
- Epstein–Barr virus: LMP1 masquerades as an active receptorCurrent Biology, 1998
- Differences in the growth pattern and clinical course of EBV-LMP1 expressing and non-expressing nasopharyngeal carcinomasEuropean Journal Of Cancer, 1995
- Epstein-Barr virus (EBV)-encoded membrane protein LMP1 from a nasopharyngeal carcinoma is non-immunogenic in a murine model system, in contrast to a B cell-derived homologueEuropean Journal Of Cancer, 1994
- Sequence variation in the Epstein--Barr virus latent membrane protein 1Journal of General Virology, 1994
- Epstein--Barr virus types 1 and 2 have nearly identical LMP-1 transforming genesJournal of General Virology, 1994
- Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's diseaseThe Lancet, 1991